Genoway SA
PAR:ALGEN

Watchlist Manager
Genoway SA Logo
Genoway SA
PAR:ALGEN
Watchlist
Price: 3.8 EUR -0.78% Market Closed
Market Cap: 35.2m EUR
Have any thoughts about
Genoway SA?
Write Note

Genoway SA
Total Liabilities & Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Genoway SA
Total Liabilities & Equity Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities & Equity CAGR 3Y CAGR 5Y CAGR 10Y
Genoway SA
PAR:ALGEN
Total Liabilities & Equity
€31.7m
CAGR 3-Years
1%
CAGR 5-Years
10%
CAGR 10-Years
12%
Valneva SE
PAR:VLA
Total Liabilities & Equity
€466.6m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Innate Pharma SA
PAR:IPH
Total Liabilities & Equity
€151.5m
CAGR 3-Years
-17%
CAGR 5-Years
-16%
CAGR 10-Years
4%
G
Genfit SA
PAR:GNFT
Total Liabilities & Equity
€194.8m
CAGR 3-Years
13%
CAGR 5-Years
-10%
CAGR 10-Years
10%
Inventiva SA
PAR:IVA
Total Liabilities & Equity
€39.4m
CAGR 3-Years
-30%
CAGR 5-Years
-8%
CAGR 10-Years
N/A
Eurobio Scientific SA
PAR:ALERS
Total Liabilities & Equity
€316.3m
CAGR 3-Years
21%
CAGR 5-Years
35%
CAGR 10-Years
22%
No Stocks Found

Genoway SA
Glance View

Market Cap
33.1m EUR
Industry
Biotechnology

genOway SA engages in the development of genetically-modified mouse, rat, and cellular models for biopharmaceutical and research companies. The company is headquartered in Lyon, Auvergne-Rhone-Alpes. The company went IPO on 2007-05-04. The firm offers an array of services which include site specific transgenesis, random insertion based transgenic models, gene overexpression, humanization, gene deletion and gene knock-down (RNA interference). The Company’s clients include multinational biopharmaceutical companies, such as Roche, Novartis and Servier, as well as universities and research institutes, notably Boston University, University of Tokyo, Johann Wolfgang Goethe University Hospital Frankfurt and Centre National de Genotypage.

ALGEN Intrinsic Value
4.89 EUR
Undervaluation 22%
Intrinsic Value
Price

See Also

What is Genoway SA's Total Liabilities & Equity?
Total Liabilities & Equity
31.7m EUR

Based on the financial report for Jun 30, 2024, Genoway SA's Total Liabilities & Equity amounts to 31.7m EUR.

What is Genoway SA's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 10Y
12%

Over the last year, the Total Liabilities & Equity growth was -3%. The average annual Total Liabilities & Equity growth rates for Genoway SA have been 1% over the past three years , 10% over the past five years , and 12% over the past ten years .

Back to Top